Company intelligence / Profile preview

Konapharma

Pratteln, Basel-Landschaft (Basel District), Switzerlandkonapharma.ch ↗

Ownership: Private
Employees: ~81
Development stage: Commercial

Overview

Konapharma is a Swiss contract manufacturer specializing in the development and manufacturing of solid dosage forms, including complex formulations such as MUPS (multi unit pellet systems), retard forms, and bi-layered tablets. The company also provides primary and secondary packaging services, clinical sample production, and has special licenses for handling narcotics. It is approved by major regulatory agencies including Swissmedic, FDA, ANVISA, and TMMDA[1][4][5][6]. In June 2024, it was acquired by Rhenopharma Group[2][8].

Modalities: Small moleculeSolid dosage forms
Industry: Contract Manufacturing Organization

Partnerships

RhenochemAllpack (as part of the Rhenopharma Group)[2]

Beyond the preview

Go deeper on Konapharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Konapharma.

Explore the full profile